Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study

被引:22
作者
Al-Eitan, Laith N. [1 ,2 ]
Jamous, Reem I. [1 ,2 ]
Khasawneh, Rame H. [3 ]
机构
[1] Jordan Univ Sci & Technol, Dept Appl Biol Sci, Irbid, Jordan
[2] Jordan Univ Sci & Technol, Dept Biotechnol & Genet Engn, Irbid, Jordan
[3] Jordan Royal Med Serv RMS, KHMC, Dept Hematopathol, Amman, Jordan
关键词
Breast cancer; Jordanian Arabs; genetic association; case-control study; BRCA2; MUTATIONS; DAP-KINASE; SUSCEPTIBILITY GENES; COMMON VARIANTS; FAMILY-HISTORY; PROTEIN-KINASE; RISK; POLYMORPHISMS; TP53; MATRIX-METALLOPROTEINASE-9;
D O I
10.1080/07357907.2017.1289217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to investigate whether there are specific polymorphisms within six genes (BRCA1, BRCA2, TP53, DAPK1, MMP9 promoter, and TOX3) that are associated with breast cancer among the Jordanian population. Sequenom MassARRAY system was used to genotype 17 single nucleotide polymorphisms (SNPs) within these genes in 230 Jordanian breast cancer patients and 225 healthy individuals. Three SNPs (MMP9 (rs6065912), TOX3 (rs1420546), and DAPK1 (rs11141901) were found to be significantly associated with an increased risk of breast cancer (p < .05). This study is the first to provide evidence that genetic variation in MMP9, TOX3, and DAPK1 genes contribute to the development of breast cancer in the Jordanian population.
引用
收藏
页码:256 / 270
页数:15
相关论文
共 85 条
[1]  
Alberts B., 2002, Molecular Biology of the Cell. (4th edition), V4th ed
[2]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[3]   A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Stratton, MR ;
Peto, J ;
Ponder, BJ ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83
[4]   Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Ponder, BAJ ;
Easton, D .
GENETIC EPIDEMIOLOGY, 2001, 21 (01) :1-18
[5]   Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts [J].
Baquero, Maria T. ;
Lostritto, Karen ;
Gustavson, Mark D. ;
Bassi, Kimberly A. ;
Appia, Franck ;
Camp, Robert L. ;
Molinaro, Annette M. ;
Harris, Lyndsay N. ;
Rimm, David L. .
BREAST CANCER RESEARCH, 2011, 13 (05)
[6]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[7]   Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk [J].
Baynes, Caroline ;
Healey, Catherine S. ;
Pooley, Karen A. ;
Scollen, Serena ;
Luben, Robert N. ;
Thompson, Deborah J. ;
Pharoah, Paul D. P. ;
Easton, Douglas F. ;
Ponder, Bruce A. J. ;
Dunning, Alison M. .
BREAST CANCER RESEARCH, 2007, 9 (02)
[8]   The death-associated protein kinases: Structure, function, and beyond [J].
Bialik, Shani ;
Kimchi, Adi .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :189-210
[9]   TP53 and breast cancer [J].
Borresen-Dale, AL .
HUMAN MUTATION, 2003, 21 (03) :292-300
[10]   Intronic alterations in BRCA1 and BRCA2:: Effect on mRNA splicing fidelity and expression [J].
Chen, XW ;
Truong, TTN ;
Weaver, J ;
Bove, BA ;
Cattie, K ;
Armstrong, BA ;
Daly, MB ;
Godwin, AK .
HUMAN MUTATION, 2006, 27 (05) :427-435